Literature DB >> 22491475

NLRC5 regulates MHC class I antigen presentation in host defense against intracellular pathogens.

Yikun Yao1, Yalong Wang, Fuxiang Chen, Yin Huang, Shu Zhu, Qibin Leng, Hongyan Wang, Yufang Shi, Youcun Qian.   

Abstract

NOD-like receptors (NLRs) are a family of intracellular proteins that play critical roles in innate immunity against microbial infection. NLRC5, the largest member of the NLR family, has recently attracted much attention. However, in vitro studies have reported inconsistent results about the roles of NLRC5 in host defense and in regulating immune signaling pathways. The in vivo function of NLRC5 remains unknown. Here, we report that NLRC5 is a critical regulator of host defense against intracellular pathogens in vivo. NLRC5 was specifically required for the expression of genes involved in MHC class I antigen presentation. NLRC5-deficient mice showed a profound defect in the expression of MHC class I genes and a concomitant failure to activate L. monocytogenes-specific CD8(+) T cell responses, including activation, proliferation and cytotoxicity, and the mutant mice were more susceptible to the pathogen infection. NLRP3-mediated inflammasome activation was also partially impaired in NLRC5-deficient mice. However, NLRC5 was dispensable for pathogen-induced expression of NF-κB-dependent pro-inflammatory genes as well as type I interferon genes. Thus, NLRC5 critically regulates MHC class I antigen presentation to control intracellular pathogen infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22491475      PMCID: PMC3346158          DOI: 10.1038/cr.2012.56

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  28 in total

1.  A role for the human nucleotide-binding domain, leucine-rich repeat-containing family member NLRC5 in antiviral responses.

Authors:  Andreas Neerincx; Katja Lautz; Maureen Menning; Elisabeth Kremmer; Paola Zigrino; Marianna Hösel; Hildegard Büning; Robert Schwarzenbacher; Thomas A Kufer
Journal:  J Biol Chem       Date:  2010-06-10       Impact factor: 5.157

Review 2.  The inflammasomes.

Authors:  Kate Schroder; Jurg Tschopp
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

3.  NLRC5 limits the activation of inflammatory pathways.

Authors:  Szilvia Benko; Joao G Magalhaes; Dana J Philpott; Stephen E Girardin
Journal:  J Immunol       Date:  2010-07-07       Impact factor: 5.422

4.  NLRC5 deficiency does not influence cytokine induction by virus and bacteria infections.

Authors:  Himanshu Kumar; Surya Pandey; Jian Zou; Yutaro Kumagai; Ken Takahashi; Shizuo Akira; Taro Kawai
Journal:  J Immunol       Date:  2010-12-08       Impact factor: 5.422

Review 5.  Intracellular NOD-like receptors in host defense and disease.

Authors:  Thirumala-Devi Kanneganti; Mohamed Lamkanfi; Gabriel Núñez
Journal:  Immunity       Date:  2007-10       Impact factor: 31.745

6.  NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways.

Authors:  Jun Cui; Liang Zhu; Xiaojun Xia; Helen Y Wang; Xavier Legras; Jun Hong; Jiabing Ji; Pingping Shen; Shu Zheng; Zhijian J Chen; Rong-Fu Wang
Journal:  Cell       Date:  2010-04-30       Impact factor: 41.582

Review 7.  Central roles of NLRs and inflammasomes in viral infection.

Authors:  Thirumala-Devi Kanneganti
Journal:  Nat Rev Immunol       Date:  2010-09-17       Impact factor: 53.106

8.  NLR family member NLRC5 is a transcriptional regulator of MHC class I genes.

Authors:  Torsten B Meissner; Amy Li; Amlan Biswas; Kyoung-Hee Lee; Yuen-Joyce Liu; Erkan Bayir; Dimitrios Iliopoulos; Peter J van den Elsen; Koichi S Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-16       Impact factor: 11.205

9.  Listeria monocytogenes-infected human peripheral blood mononuclear cells produce IL-1beta, depending on listeriolysin O and NLRP3.

Authors:  Karolin Meixenberger; Florence Pache; Julia Eitel; Bernd Schmeck; Stefan Hippenstiel; Hortense Slevogt; Philippe N'Guessan; Martin Witzenrath; Mihai G Netea; Trinad Chakraborty; Norbert Suttorp; Bastian Opitz
Journal:  J Immunol       Date:  2009-12-11       Impact factor: 5.422

10.  Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling.

Authors:  Shu Zhu; Wen Pan; Peiqing Shi; Hanchao Gao; Fang Zhao; Xinyang Song; Yan Liu; Lihua Zhao; Xiaoxia Li; Yufang Shi; Youcun Qian
Journal:  J Exp Med       Date:  2010-11-15       Impact factor: 14.307

View more
  67 in total

1.  Post-transcriptional inhibition of luciferase reporter assays by the Nod-like receptor proteins NLRX1 and NLRC3.

Authors:  Arthur Ling; Fraser Soares; David O Croitoru; Ivan Tattoli; Leticia A M Carneiro; Michele Boniotto; Szilvia Benko; Dana J Philpott; Stephen E Girardin
Journal:  J Biol Chem       Date:  2012-06-20       Impact factor: 5.157

Review 2.  NLRC5/CITA: A Key Player in Cancer Immune Surveillance.

Authors:  Sayuri Yoshihama; Saptha Vijayan; Tabasum Sidiq; Koichi S Kobayashi
Journal:  Trends Cancer       Date:  2017-01-10

3.  NLRC5: a NOD-like receptor protein with many faces in immune regulation.

Authors:  Yue Zhao; Feng Shao
Journal:  Cell Res       Date:  2012-05-22       Impact factor: 25.617

4.  Manipulation of EAT-2 expression promotes induction of multiple beneficial regulatory and effector functions of the human innate immune system as a novel immunomodulatory strategy.

Authors:  Yasser A Aldhamen; Sergey S Seregin; Charles F Aylsworth; Sarah Godbehere; Andrea Amalfitano
Journal:  Int Immunol       Date:  2013-12-27       Impact factor: 4.823

5.  Deficiency of the NOD-Like Receptor NLRC5 Results in Decreased CD8+ T Cell Function and Impaired Viral Clearance.

Authors:  Christopher R Lupfer; Kate L Stokes; Teneema Kuriakose; Thirumala-Devi Kanneganti
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

6.  Cancer Cell-targeted and Activatable Photoimmunotherapy Spares T Cells in a 3D Coculture Model.

Authors:  Eric M Kercher; Shubhankar Nath; Imran Rizvi; Bryan Q Spring
Journal:  Photochem Photobiol       Date:  2019-10-13       Impact factor: 3.421

7.  NLRC5/MHC class I transactivator is a target for immune evasion in cancer.

Authors:  Sayuri Yoshihama; Jason Roszik; Isaac Downs; Torsten B Meissner; Saptha Vijayan; Bjoern Chapuy; Tabasum Sidiq; Margaret A Shipp; Gregory A Lizee; Koichi S Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

Review 8.  Inflammasomes in Myeloid Cells: Warriors Within.

Authors:  Sushmita Jha; W June Brickey; Jenny Pan-Yun Ting
Journal:  Microbiol Spectr       Date:  2017-01

Review 9.  Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.

Authors:  Saptha Vijayan; Tabasum Sidiq; Suhail Yousuf; Peter J van den Elsen; Koichi S Kobayashi
Journal:  Immunogenetics       Date:  2019-01-31       Impact factor: 2.846

Review 10.  Listeria monocytogenes and the Inflammasome: From Cytosolic Bacteriolysis to Tumor Immunotherapy.

Authors:  Erin Theisen; John-Demian Sauer
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.